Delivery Order SPE2DB20D1100-SPE2DB25FA1N5

Award Date 1/17/25
Potential Completion Date 2/10/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,687.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,687.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 20, 2024, with a completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,687.18, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 25, 2025. This award is not part of a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,061.54 Firm Fixed Price Delivery Order is for the medical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through April 9, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a $7,030.77 firm-fixed-price delivery order awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the medical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through April 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product, with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed price delivery order covers the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a completion date of February 18, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, to support military healthcare programs. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA1N5
    Delivery Order

This award is a $4,687.18 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated with a set-aside requirement, indicating open competition.

Generated 4/18/25, 2:15 PM